{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-011336","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2025-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.650004+00:00","generated_at":"2026-05-18T03:41:21.098193+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Mangoceuticals amends CEO trust note to convertible with warrants; conversion price $1.785","bullets":["Amended $100k promissory note from CEO's Tiger Cub Trust into convertible note; conversion price set at $1.785/share.","Issued warrants to Tiger Cub Trust to purchase 50,000 shares at $1.815/share, expiring July 21, 2028.","Removed mandatory prepayment requirement upon qualified financing.","Indigo Capital converted $500k note plus $90k interest into 393,333 shares at $1.50/share.","Sold 261,667 shares under ELOC at $1.5645/share for net proceeds of $409,367."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-011336","json":"https://secwatch.observer/filing/0001493152-25-011336.json","markdown":"https://secwatch.observer/filing/0001493152-25-011336.md","text":"https://secwatch.observer/filing/0001493152-25-011336.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315225011336/0001493152-25-011336-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315225011336/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T03:41:21.098193+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}